Related changes
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are shown in bold with a green bullet. See more at Help:Related changes.
List of abbreviations (help):
- D
- Edit made at Wikidata
- r
- Edit flagged by ORES
- N
- New page
- m
- Minor edit
- b
- Bot edit
- (±123)
- Page byte size change
- Temporarily watched page
20 May 2024
- diffhist m Insulin-like growth factor 1 21:05 −4 Bendegúz Ács talk contribs (→Causes of elevated IGF-1 levels: Copyedit) Tag: Visual edit
- diffhist m Insulin-like growth factor 1 21:04 +5 Bendegúz Ács talk contribs (→Causes of elevated IGF-1 levels: Improve grammar) Tag: Visual edit
- diffhist Insulin-like growth factor 1 21:04 +620 Bendegúz Ács talk contribs (Added content about the effect of calorie restriction on IGF-1 levels) Tag: Visual edit
- diffhist Insulin-like growth factor 1 19:43 +150 Bendegúz Ács talk contribs (→Health effects: Split findings of Mendelian randomization study, added precise figures) Tag: Visual edit
- diffhist Insulin-like growth factor 1 19:38 +109 Bendegúz Ács talk contribs (Moved results of Mendelian randomization study to Health effects section, added attribution since this is a primary study (see WP:MEDASSESS)) Tag: Visual edit
- diffhist Insulin-like growth factor 1 19:34 +3 A455bcd9 talk contribs (→Causes of elevated IGF-1 levels: capitalization) Tag: 2017 wikitext editor
- diffhist Insulin-like growth factor 1 19:25 +71 Bendegúz Ács talk contribs (Undid revision 1224800604 by A455bcd9 (talk) - the most relevant sentence in this source [https://link.springer.com/article/10.1007/s40618-022-01819-1] is confusing, but the rest of the abstract makes it clear. Perhaps a more understandable phrasing would be "for the highest IGF-1 levels compared to the lowest". Also, please first edit the Health effects section, then the lead.) Tag: Undo
- diffhist Lymphatic system 17:34 0 Tescomealdeal1 talk contribs (Reverted 1 edit by 2600:1009:B056:F931:B839:A1FE:DE56:187A (talk): Unconstructive) Tags: Twinkle Undo
- diffhist Lymphatic system 17:33 0 2600:1009:b056:f931:b839:a1fe:de56:187a talk Tags: Reverted Mobile edit Mobile web edit
- diffhist m Lymphatic system 17:33 +7 Tescomealdeal1 talk contribs (Reverted 1 edit by 2600:1009:B056:F931:B839:A1FE:DE56:187A (talk) to last revision by Iztwoz) Tags: Twinkle Undo
- diffhist Lymphatic system 17:32 −7 2600:1009:b056:f931:b839:a1fe:de56:187a talk Tags: Reverted Mobile edit Mobile web edit
- diffhist Testosterone 15:37 −176 Tpbradbury talk contribs (→Aggression and criminality {{anchor|Aggression}}{{anchor|Criminality}}: not that long)
- diffhist Insulin-like growth factor 1 14:57 −71 A455bcd9 talk contribs (No? (unless I didn't understand the Mendelian randomization cited)) Tags: Reverted 2017 wikitext editor
- diffhist Insulin-like growth factor 1 14:57 −109 A455bcd9 talk contribs (→Synthesis and circulation: The article says the exact opposite) Tag: 2017 wikitext editor
- diffhist Nivolumab 14:47 +1,006 Yeshu972 talk contribs (→Medical uses: I made edits for grammar, tone, and clarity. I rewrote the mechanism of action section, as well.) Tag: Visual edit
- diffhist Module:Pagetype/rfd 13:04 +27 MSGJ talk contribs (+Rfd-NPF/core)
- diffhist Module:Pagetype/rfd 13:03 +22 MSGJ talk contribs (+Rfd-NPF, seen on West Ardougne)
- diffhist m Insulin-like growth factor 1 12:38 +5 Bendegúz Ács talk contribs (→Use as a diagnostic test: Fixed grammar) Tag: Visual edit
- diffhist Insulin-like growth factor 1 12:37 −1,418 Bendegúz Ács talk contribs (→Clinical trials: Removed overly detailed content about Mecasermin that is covered adequately in Mecasermin) Tag: Visual edit
- diffhist Insulin-like growth factor 1 12:35 −165 Bendegúz Ács talk contribs (→Clinical trials: Moved content about other conditions to IMecasermin) Tag: Visual edit
- diffhist Mecasermin 12:33 +378 Bendegúz Ács talk contribs (Moved content about other conditions from Insulin-like growth factor 1) Tag: Visual edit
- diffhist Insulin-like growth factor 1 09:46 −2,293 Bendegúz Ács talk contribs (→Laron syndrome: Replaced content on Laron syndrome with an excerpt from its lead section) Tag: Visual edit
- diffhist m Dexamethasone 03:20 −1 SimLibrarian talk contribs (periods only for complete-sentence image captions (MOS:CAPFRAG), minor ce) Tag: Visual edit
19 May 2024
- diffhist Obinutuzumab 18:04 −35 Rofraja talk contribs (No bare URLs. Remove bare URLs marker)
- diffhist Obinutuzumab 17:36 +81 Rofraja talk contribs (Fix bare URLs references, add title)
- diffhist Module:List 16:45 +78 Pppery talk contribs (Per edit request)
- diffhist Testosterone 08:19 +8 Pipe058 talk contribs (Reverting edit(s) by 218.252.11.94 (talk) to rev. 1224588588 by Beland: Vandalism (RW 16.1)) Tags: RW Undo
- diffhist Testosterone 08:19 −8 218.252.11.94 talk Tag: Reverted
- diffhist m Testosterone 07:39 0 Beland talk contribs (change U+00B5 to U+03BC (μ) per Unicode standard and MOS:NUM#Specific units - see Unicode compatibility characters (via WP:JWB))
- diffhist m Rituximab 06:34 0 Beland talk contribs (change U+00B5 to U+03BC (μ) per Unicode standard and MOS:NUM#Specific units - see Unicode compatibility characters (via WP:JWB))
- diffhist m Receptor modulator 02:36 0 Beland talk contribs (change U+00B5 to U+03BC (μ) per Unicode standard and MOS:NUM#Specific units - see Unicode compatibility characters (via WP:JWB))
18 May 2024
- diffhist Food and Drug Administration 19:33 −81 Skm989898 talk contribs
- diffhist Insulin-like growth factor 1 10:06 −1,014 Bendegúz Ács talk contribs (→Clinical trials: Removed content based entirely on an old single study) Tag: Visual edit
- diffhist m Durvalumab 03:05 −2 Whywhenwhohow talk contribs (script-assisted date audit and style fixes per MOS:NUM)
- diffhist m Tisotumab vedotin 03:04 +1 Whywhenwhohow talk contribs (script-assisted date audit and style fixes per MOS:NUM)
- diffhist m Tarlatamab 01:53 −1 Whywhenwhohow talk contribs (→top: remove blank line)
- diffhist Tarlatamab 01:53 0 Whywhenwhohow talk contribs (move ref)
- diffhist Template:Targeted cancer therapeutic agents 01:51 +17 Whywhenwhohow talk contribs (add Tarlatamab)
- diffhist Tarlatamab 01:50 +154 Whywhenwhohow talk contribs (templates, cats, stubs)
- diffhist Tisotumab vedotin 01:46 +42 Whywhenwhohow talk contribs (stubs)
- diffhist Tafasitamab 01:46 +11 Whywhenwhohow talk contribs (cats)
- diffhist Retifanlimab 01:46 +42 Whywhenwhohow talk contribs (stubs)
- diffhist Naxitamab 01:45 +11 Whywhenwhohow talk contribs (cats)
- diffhist Mogamulizumab 01:45 +11 Whywhenwhohow talk contribs (cats)
- diffhist Mirvetuximab soravtansine 01:45 +42 Whywhenwhohow talk contribs (stubs)
- diffhist Bermekimab 01:45 +77 Whywhenwhohow talk contribs (stubs)
- diffhist Tremelimumab 01:44 +11 Whywhenwhohow talk contribs (cats)
- diffhist Durvalumab 01:41 +11 Whywhenwhohow talk contribs (update cats)
- diffhist Tremelimumab 01:38 +66 Whywhenwhohow talk contribs (templates)